Lüt Announces Partnership with the American Peptide Association (APA) and American IV Association (AIVA) to Deliver Compliant Payments for Peptide and Wellness Industries
Lüt has announced a strategic partnership with the American Peptide Association (APA) and the American IV Association (AIVA) to bring compliant, scalable payments infrastructure to the peptide and IV/wellness industries — two fast-growing healthcare sectors that have historically been underserved by traditional banking due to high-risk classifications, account shutdowns, and frozen operating capital.
As part of the partnership, Lüt is launching Lüt Turbo, an ACH-based payments platform built to handle both B2B and consumer transactions. The platform allows providers to send and receive payments across multiple bank accounts, plug directly into eCommerce environments, and manage invoicing through secure payment links — all inside a single system.
Key voices in the announcement:
- Michael Andrud, Founder & CEO of Lüt — frames the partnership as a shared push for transparency in the healthcare-centric financial ecosystem and a "system of trust" for operators and patients.
- Jeff Cohen, Founder of APA and AIVA — positions Lüt Turbo as the first financial infrastructure built specifically around how peptide and IV providers actually operate, freeing them from constant payment disruptions so they can focus on patient care and growth.
The takeaway: Lüt is extending its high-risk payments thesis from cannabis and iGaming into clinical wellness, and the APA/AIVA partnership gives Lüt Turbo a built-in distribution channel into thousands of peptide and IV therapy providers nationwide.
Read the full release here: https://www.businesswire.com/news/home/20260505932098/en/Lt-Announces-Partnership-with-the-American-Peptide-Association-APA-and-American-IV-Association-AIVA-to-Deliver-Compliant-Payments-for-Peptide-and-Wellness-Industries
